Evaluation of antibiotic consumption using WHO -antimicrobial consumption tool and AWaRe classification

Introduction: Antimicrobial resistance is a public health concern with global ramifications. Antibiotic misuse and overuse, are rampant in our country but more alarming is the data on the use of antibiotics primarily because of lack of access is another threat. A majority of the data on drug sales a...

Full description

Saved in:
Bibliographic Details
Main Authors: Julie Birdie Wahlang, Reuben P. Syiem, Chayna Sarkar, Nari M. Lyngdoh, Iadarilang Tiewsoh, Dhriti K. Brahma, Aitilutmon Surong, Arky J Langstieh
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2024-12-01
Series:Journal of Family Medicine and Primary Care
Subjects:
Online Access:https://journals.lww.com/10.4103/jfmpc.jfmpc_952_24
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841545817148620800
author Julie Birdie Wahlang
Reuben P. Syiem
Chayna Sarkar
Nari M. Lyngdoh
Iadarilang Tiewsoh
Dhriti K. Brahma
Aitilutmon Surong
Arky J Langstieh
author_facet Julie Birdie Wahlang
Reuben P. Syiem
Chayna Sarkar
Nari M. Lyngdoh
Iadarilang Tiewsoh
Dhriti K. Brahma
Aitilutmon Surong
Arky J Langstieh
author_sort Julie Birdie Wahlang
collection DOAJ
description Introduction: Antimicrobial resistance is a public health concern with global ramifications. Antibiotic misuse and overuse, are rampant in our country but more alarming is the data on the use of antibiotics primarily because of lack of access is another threat. A majority of the data on drug sales and consumption in India comes from the private sector and is typically gathered from private commercial organization. Because data on antibiotic usage in India is rarely reported, the study’s objectives were to estimate antibiotic consumption in ICU patients and also to assess antibiotic usage trends using the WHO AWaRE classification. Materials and Methods: A prospective observational study was carried out in the ICU department for six months after obtaining institutional ethics committee approval (P14/2021/14). In-patient records and details on antibiotic prescriptions were collected from the day of admission until they were discharged from the intensive care unit. Data on antibiotic consumption were retrieved from the hospital pharmacy. Descriptive statistics such as frequency, percentages, and means were used to summarize the data. Microsoft Excel 2016 was used for all statistical analyses. Results: The results of the study showed that female patients (54%), made up a significant majority of those receiving antimicrobial treatment. The age group between 40–49 years (21.68%) was the most common for those receiving antimicrobial treatment. Surgical prophylaxis (37.34%) emerged as the most common indication. Among the different antimicrobials studied, ceftriaxone 1 gm (108.5 DDD) emerged as the most prescribed antimicrobial. The access group of antibiotics accounted for 55% of the total usage. Conclusion: Appropriate use of antibiotics is important to minimize the risk of adverse events and antimicrobial resistance.
format Article
id doaj-art-4761c6f7898547e79f6afb5db45c9d91
institution Kabale University
issn 2249-4863
2278-7135
language English
publishDate 2024-12-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Journal of Family Medicine and Primary Care
spelling doaj-art-4761c6f7898547e79f6afb5db45c9d912025-01-11T10:09:30ZengWolters Kluwer Medknow PublicationsJournal of Family Medicine and Primary Care2249-48632278-71352024-12-0113125805581110.4103/jfmpc.jfmpc_952_24Evaluation of antibiotic consumption using WHO -antimicrobial consumption tool and AWaRe classificationJulie Birdie WahlangReuben P. SyiemChayna SarkarNari M. LyngdohIadarilang TiewsohDhriti K. BrahmaAitilutmon SurongArky J LangstiehIntroduction: Antimicrobial resistance is a public health concern with global ramifications. Antibiotic misuse and overuse, are rampant in our country but more alarming is the data on the use of antibiotics primarily because of lack of access is another threat. A majority of the data on drug sales and consumption in India comes from the private sector and is typically gathered from private commercial organization. Because data on antibiotic usage in India is rarely reported, the study’s objectives were to estimate antibiotic consumption in ICU patients and also to assess antibiotic usage trends using the WHO AWaRE classification. Materials and Methods: A prospective observational study was carried out in the ICU department for six months after obtaining institutional ethics committee approval (P14/2021/14). In-patient records and details on antibiotic prescriptions were collected from the day of admission until they were discharged from the intensive care unit. Data on antibiotic consumption were retrieved from the hospital pharmacy. Descriptive statistics such as frequency, percentages, and means were used to summarize the data. Microsoft Excel 2016 was used for all statistical analyses. Results: The results of the study showed that female patients (54%), made up a significant majority of those receiving antimicrobial treatment. The age group between 40–49 years (21.68%) was the most common for those receiving antimicrobial treatment. Surgical prophylaxis (37.34%) emerged as the most common indication. Among the different antimicrobials studied, ceftriaxone 1 gm (108.5 DDD) emerged as the most prescribed antimicrobial. The access group of antibiotics accounted for 55% of the total usage. Conclusion: Appropriate use of antibiotics is important to minimize the risk of adverse events and antimicrobial resistance.https://journals.lww.com/10.4103/jfmpc.jfmpc_952_24antimicrobial consumptionaware classificationdefined daily dose
spellingShingle Julie Birdie Wahlang
Reuben P. Syiem
Chayna Sarkar
Nari M. Lyngdoh
Iadarilang Tiewsoh
Dhriti K. Brahma
Aitilutmon Surong
Arky J Langstieh
Evaluation of antibiotic consumption using WHO -antimicrobial consumption tool and AWaRe classification
Journal of Family Medicine and Primary Care
antimicrobial consumption
aware classification
defined daily dose
title Evaluation of antibiotic consumption using WHO -antimicrobial consumption tool and AWaRe classification
title_full Evaluation of antibiotic consumption using WHO -antimicrobial consumption tool and AWaRe classification
title_fullStr Evaluation of antibiotic consumption using WHO -antimicrobial consumption tool and AWaRe classification
title_full_unstemmed Evaluation of antibiotic consumption using WHO -antimicrobial consumption tool and AWaRe classification
title_short Evaluation of antibiotic consumption using WHO -antimicrobial consumption tool and AWaRe classification
title_sort evaluation of antibiotic consumption using who antimicrobial consumption tool and aware classification
topic antimicrobial consumption
aware classification
defined daily dose
url https://journals.lww.com/10.4103/jfmpc.jfmpc_952_24
work_keys_str_mv AT juliebirdiewahlang evaluationofantibioticconsumptionusingwhoantimicrobialconsumptiontoolandawareclassification
AT reubenpsyiem evaluationofantibioticconsumptionusingwhoantimicrobialconsumptiontoolandawareclassification
AT chaynasarkar evaluationofantibioticconsumptionusingwhoantimicrobialconsumptiontoolandawareclassification
AT narimlyngdoh evaluationofantibioticconsumptionusingwhoantimicrobialconsumptiontoolandawareclassification
AT iadarilangtiewsoh evaluationofantibioticconsumptionusingwhoantimicrobialconsumptiontoolandawareclassification
AT dhritikbrahma evaluationofantibioticconsumptionusingwhoantimicrobialconsumptiontoolandawareclassification
AT aitilutmonsurong evaluationofantibioticconsumptionusingwhoantimicrobialconsumptiontoolandawareclassification
AT arkyjlangstieh evaluationofantibioticconsumptionusingwhoantimicrobialconsumptiontoolandawareclassification